{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T02:19:56Z","timestamp":1774145996220,"version":"3.50.1"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100015150","name":"St. Michael's Hospital Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015150","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MitogenDx"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00134-021-06408-z","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T03:50:46Z","timestamp":1619754646000},"page":"801-804","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["COVID-19-associated autoimmunity as a feature of acute respiratory failure"],"prefix":"10.1007","volume":"47","clinical-trial-number":[{"clinical-trial-number":"nct04747782","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Uriel","family":"Trahtemberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1652-6608","authenticated-orcid":false,"given":"Marvin J.","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"On behalf of the COVID-19 chapter of the \u201cLongitudinal Biomarkers in Lung Injury\u201d study group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Rottapel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia C.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex P.","family":"Di Battista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur S.","family":"Slutsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"key":"6408_CR1","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1136\/annrheumdis-2020-218009","volume":"79","author":"PG Vlachoyiannopoulos","year":"2020","unstructured":"Vlachoyiannopoulos PG, Magira E, Alexopoulos H, Jahaj E, Theophilopoulou K, Kotanidou A, Tzioufas AG (2020) Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann Rheum Dis 79:1661\u20131663","journal-title":"Ann Rheum Dis"},{"key":"6408_CR2","doi-asserted-by":"publisher","first-page":"100073","DOI":"10.1016\/j.jtauto.2020.100073","volume":"3","author":"LA Lerma","year":"2020","unstructured":"Lerma LA, Chaudhary A, Bryan A, Morishima C, Wener MH, Fink SL (2020) Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19). J Transl Autoimmun 3:100073. https:\/\/doi.org\/10.1016\/j.jtauto.2020.100073","journal-title":"J Transl Autoimmun"},{"key":"6408_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12953","author":"MC Sacchi","year":"2020","unstructured":"Sacchi MC, Tamiazzo S, Stobbione P, Agatea L, De GP, Stecca A et al (2020) SARS-CoV-2 infection as a trigger of autoimmune response. Clin Transl Sci. https:\/\/doi.org\/10.1111\/cts.12953","journal-title":"Clin Transl Sci"},{"key":"6408_CR4","doi-asserted-by":"publisher","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","volume":"370","author":"P Bastard","year":"2020","unstructured":"Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y et al (2020) Auto-antibodies against type I IFNs in patients with life-threatening COVID-19. Science 370:eabd4585. https:\/\/doi.org\/10.1126\/science.abd4585","journal-title":"Science"},{"key":"6408_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1479-5876-8-97","volume":"8","author":"PD Burbelo","year":"2010","unstructured":"Burbelo PD, Seam N, Groot S, Ching KH, Han BL, Meduri GU et al (2010) Rapid induction of autoantibodies during ARDS and septic shock. J Transl Med 8:97\u201398. https:\/\/doi.org\/10.1186\/1479-5876-8-97","journal-title":"J Transl Med"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-021-06408-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-021-06408-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-021-06408-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T13:45:12Z","timestamp":1628603112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-021-06408-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["6408"],"URL":"https:\/\/doi.org\/10.1007\/s00134-021-06408-z","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]},"assertion":[{"value":"5 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MJF is the Director of MitogenDx. MJF is a consultant for and received speaking honoraria from Inova Diagnostics Inc (San Diego, CA) and Werfen International (Barcelona, Spain). All the other authors have no disclosures to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}},{"value":"This research was approved by the Research Ethics Boards of St Michael\u2019s Hospital and performed in accordance with the Helsinki Declaration of 1975 as revised in 2013.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patients or surrogate decision makers when available. Otherwise, as per the study\u2019s protocol and as approved by the REB, given the minimal-risk nature of the study, a deferred consent model was invoked while continuing to pursue direct consent throughout the study period.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"NCT04747782\u2014clinicaltrials.gov.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study registration"}}]}}